The Research
Learn more about the research findings from the IPF-PRO/ILD-PRO Registry using the sortable list of publications and abstracts below.
2,000+
patients enrolled
100+
conference abstracts presented
25+
journal articles published
All Publications and Abstracts
| Type | Year | Title, Author, and Congress | Article | Smart Poster (where applicable) |
|---|---|---|---|---|
| Publication | 2026 | High density lipoproteins, disease severity and clinical outcomes in patients with idiopathic pulmonary fibrosis. Podolanczuk AJ, Mulder H, Kim JS, Neely ML, Kaner RJ, Todd JL. | Abstract/Publication | |
| Publication | 2025 | Mass spectrometry-based peripheral blood proteomics for biomarker discovery in idiopathic pulmonary fibrosis. Menon AA, Gansen B, Mulder H, Neely ML, Papavasileiou P, Salisbury ML, Southern BD, Hesslinger C, Leonard TB, Meissner F, Todd JL. | Abstract/Publication | |
| Publication | 2025 | Changes in Lung Function and Patient-Reported Outcomes in Patients with Idiopathic Pulmonary Fibrosis. Todd JL, Neely ML, Hellkamp AS, Culver DA, Oldham JM, Li P, Patel DC, Palmer SM. | Abstract/Publication | |
| Publication | 2025 | Hospitalizations in patients with idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry and EMPIRE. Nick N, Studnicka M, Gregor J, Ovesná P, Koziar Vašáková M, Simmons W, Li Y, Strek ME, Li P, Snyder LD, Olson AL, Kim HJ, Kaner RJ. | Abstract/Publication | |
| Presentation | 2025 | Survival in patients with progressive pulmonary fibrosis: data from the ILD-PRO. Registry. Belperio JA, Weber JM, Neely ML, Swaminathan AC, Bracken SJ, Chauffe A, Palmer SM on behalf of the IPF-PRO Registry investigators. Pulmonary Fibrosis Foundation (PFF) Summit 2025. | Online version not available | Smart Poster |
| Presentation | 2025 | Multiprotein predictor of short-term mortality in idiopathic pulmonary fibrosis (IPF). Todd JL, Mulder H, Neely ML, Wu P, Belperio JA, Maher TM, Oldham JM, Palmer SM, Patel DC, Schlange T, Hesslinger C on behalf of the IPF-PRO Registry investigators. European Respiratory Society Congress 2025. | Online version not available | Smart Poster |
| Presentation | 2025 | Circulating urokinase-type plasminogen activator receptor (uPAR) associates with progression of idiopathic pulmonary fibrosis (IPF). Todd JL, Mulder H, Neely ML, Wu P, Belperio JA, Maher TM, Oldham JM, Palmer SM, Patel DC, Hesslinger C, Schlange T on behalf of the IPF-PRO Registry investigators. European Respiratory Society Congress 2025. | Online version not available | Smart Poster |
| Presentation | 2025 | Transplant-free survival in patients with systemic autoimmune rheumatic diseases and progressive pulmonary fibrosis in the ILD-PRO Registry. Bracken SJ, Weber JM, Neely ML, Swaminathan AC, Palmer SM, Wilfong EM, Chauffe A, Volkmann ER on behalf of the IPF-PRO Registry investigators. American College of Rheumatology (ACR) Convergence 2025. | Abstract/Publication | Smart Poster |
| Presentation | 2025 | Transplant-free survival in patients with systemic autoimmune rheumatic diseases and progressive pulmonary fibrosis in the ILD-PRO Registry. Bracken SJ, Swaminathan AC, Weber JM, Neely ML, Palmer SM, Wilfong EM, Chauffe A, Volkmann ER on behalf of the IPF-PRO Registry investigators. WASOG /AASOG. | Online version not available | Smart Poster |
| Presentation | 2025 | Changes in circulating ICAM-1 and disease progression in patients with idiopathic pulmonary fibrosis. Todd JL, Page C, Wu P, Belperio JA, Maher TM, Palmer SM, Hesslinger C, Neely ML, Schlange T on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2025. | Abstract/Publication | Smart Poster |
| Presentation | 2025 | Association between a 7-gene signature and risk of progression in patients with idiopathic pulmonary fibrosis. Karampitsakos T, Bandyopadhyay D, Tourki B, Neely ML, Todd JL, Herazo-Maya JD on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2025. | Abstract/Publication | Smart Poster |
| Presentation | 2025 | Influence of sociodemographic characteristics on clinical trial participation among patients with idiopathic pulmonary fibrosis. Swaminathan AC, Wojdyla DM, Neely ML, Snyder LD, de Andrade JA, Patel DC, Palmer SM on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2025. | Abstract/Publication | Smart Poster |
| Presentation | 2025 | Higher acute exposure to air pollution is associated with respiratory hospitalizations in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Sack C, Wojdyla DM, MacMurdo M, Gassett A, Redlich CA, Raghu G, Kaufman JD, Olson AL, Neely ML, Snyder LD, Gulati M on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2025. | Abstract/Publication | Smart Poster |
| Presentation | 2025 | Workplace productivity loss in patients with progressive pulmonary fibrosis: data from the ILD-PRO Registry. Shetty S, Swaminathan AC, Neely ML, Olson AL, Li P, Snyder LD on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2025. | Abstract/Publication | Smart Poster |
| Presentation | 2025 | Transplant-free survival in patients with progressive pulmonary fibrosis in the ILD-PRO Registry. Belperio JA, Weber JM, Neely ML, Swaminathan AC, Bracken SJ, Chauffe A, Palmer SM on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2025. | Abstract/Publication | Smart Poster |
| Publication | 2025 | Predictors of long-term survival in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Kim HJ, Weber JM, Neely ML, Case HJ, Jbeli AH, Li P, Olson AL, Snyder LD. | Abstract/Publication | |
| Publication | 2025 | Changes in lung function and mortality risk in patients with idiopathic pulmonary fibrosis. Oldham JM, Neely ML, Wojdyla DM, Palmer SM, Todd JL, Gulati M, Li P, Patel DC. | Abstract/Publication | Smart Poster |
| Publication | 2025 | Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry. Sack C, Wojdyla DM, MacMurdo MG, Gassett A, Kaufman JD, Raghu G, Redlich CA, Li P, Olson AL, Leonard TB, Todd JL, Neely ML, Snyder LD, Gulati M. | Abstract/Publication | |
| Publication | 2025 | Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO Registry. Swaminathan AC, Weber JM, Todd JL, Palmer SM, Neely ML, Whelan TP, Kim GHJ, Leonard TB, Goldin J. | Abstract/Publication | |
| Publication | 2025 | Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis. Todd JL, Page C, Wu P, Belperio JA, Maher TM, Palmer SM, Leonard TB, Hesslinger C, Neely ML, Schlange T. | Abstract/Publication | |
| Publication | 2024 | Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Amubieya O, Todd JL, Neely ML, Kaner RJ, Lasky JA, Namen A, Hesslinger C, Palmer SM, Weigt SS, Belperio JA. | Abstract/Publication | |
| Publication | 2024 | Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease. Aparna C Swaminathan, Molly McFatrich, Laura Mkumba, Lauren Wright, Carrie A Redlich, Laurie D Snyder, Bryce B Reeve, Divya Patel, Mridu Gulati. | Abstract/Publication | |
| Publication | 2024 | Utility of the 52-gene risk score to identify patients with idiopathic pulmonary fibrosis at greater risk of mortality in the era of antifibrotic therapy. Julia F Söllner, Stefan Bentink, Christian Hesslinger, Thomas B Leonard, Megan L Neely, Nina M Patel, Thomas Schlange, Jamie L Todd, Richard Vinisko, Margaret L Salisbury. | Abstract/Publication | |
| Publication | 2024 | Design and baseline characteristics of the ILD-PRO Registry in patients with progressive pulmonary fibrosis. L Jason Lobo, Yi Liu, Peide Li, Murali Ramaswamy, Aparna C Swaminathan, Srihari Veeraraghavan, Yanni Fan, Megan L Neely, Scott M Palmer, Amy L Olson. | Abstract/Publication | |
| Publication | 2024 | Clustering-aided prediction of outcomes in patients with idiopathic pulmonary fibrosis. Lijun Wang, Peitao Wu, Yi Liu, Divya C Patel, Thomas B Leonard, Hongyu Zhao. | Abstract/Publication | |
| Publication | 2024 | Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Summer R, Todd JL, Neely ML, Lobo LJ, Namen A, Newby LK, Shafazand S, Suliman S, Hesslinger C, Keller S, Leonard TB, Palmer SM, Ilkayeva O, Muehlbauer MJ, Newgard CB, Roman J. | Abstract/Publication | |
| Publication | 2024 | Trajectories of health-related quality of life in patients with idiopathic pulmonary fibrosis. Neely ML, Todd JL, Snyder LD, Li P, Olson AL. | Abstract/Publication | |
| Publication | 2024 | Clustering-aided prediction of outcomes in patients with idiopathic pulmonary fibrosis. Wang L, Wu P, Liu Y, Patel DC, Leonard TB, Zhao H. | Abstract/Publication | |
| Publication | 2024 | Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease. Swaminathan AC, McFatrich M, Mkumba L, Wright L, Redlich CA, Snyder LD, Reeve BB, Patel D, Gulati M. | Abstract/Publication | |
| Publication | 2024 | Utility of the 52-gene risk score to identify patients with idiopathic pulmonary fibrosis at greater risk of mortality in the era of antifibrotic therapy. Söllner JF, Bentink S, Hesslinger C, Leonard TB, Neely ML, Patel NM, Schlange T, Todd JL, Vinisko R, Salisbury ML. | Abstract/Publication | |
| Presentation | 2024 | Mass spectrometry (MS)-based proteomics and mortality analysis in idiopathic pulmonary fibrosis (IPF). Gansen B, Menon AA, Mulder H, Neely ML, Hesslinger C, Salisbury ML, Southern BD, Leonard TB, Meissner F, Todd JL on behalf of the IPF-PRO Registry investigators. European Respiratory Society 2024. | Abstract/Publication | Smart Poster |
| Presentation | 2024 | Predicting long-term survival in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Kim HJ, Weber JM, Neely ML, Hajari Case A, Jbeli A, Li P, Olson AL, Snyder LD on behalf of the IPF-PRO Registry investigators. CHEST Annual Meeting 2024. | Abstract/Publication | Smart Poster |
| Presentation | 2024 | Mass spectrometry-based proteomics to evaluate the circulating proteome in idiopathic pulmonary fibrosis (IPF). Menon AA, Mulder H, Neely ML, Meissner F, Gansen B, Papavasileiou P, Hesslinger C, Salisbury ML, Southern BD, Leonard TB, Todd JL on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Presentation | 2024 | Combination of multigene profiles and clinical factors improves prediction of short-term outcomes in idiopathic pulmonary fibrosis. Swaminathan AC, Neely ML, Papavasileiou P, Hesslinger C, Noth I, Oldham JM, Schlange T, Schmid R, Leonard TB, Todd JL on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | Respiratory-related hospitalization and mechanical ventilation in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Kim HJ, Bandyopadhyay D, Neely ML, Li P, Patel D, Snyder LD on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | Changes in lung function and mortality risk in patients with idiopathic pulmonary fibrosis (IPF). Oldham JM, Neely ML, Wojdyla D, Gulati M, Li P, Patel D, Palmer SM, Todd JL on behalf of the IPF-PRO Registry investigators. European Respiratory Society 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | High-density lipoproteins, disease severity and clinical outcomes in idiopathic pulmonary fibrosis. Podolanczuk AJ, Kaner RJ, Kim JS, Neely ML, Mulder H, Leonard TB, Todd JL on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | Long-term air pollution exposure is associated with increased severity of idiopathic pulmonary fibrosis in the IPF-PRO Registry. Sack C, Wojdyla D, MacMurdo MG, Gassett A, Kaufman JD, Raghu G, Redlich CA, Li P, Olson AL, Leonard TB, Todd JL, Neely ML, Snyder LD, Gulati M on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | Clinical, imaging and treatment characteristics of patients with progressive systemic autoimmune rheumatic disease-related interstitial lung diseases (SARD-ILDs) in the ILD-PRO Registry. Swaminathan A, Weber J, Todd J, Palmer S, Neely M, Li P, Chauffe A on behalf of the ILD-PRO Registry investigators. American College of Rheumatology Convergence 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | Association of quantitative lung fibrosis (QLF) score with the severity and progression of progressive pulmonary fibrosis (PPF). Swaminathan AC, Whelan TPM, Neely ML, Todd JL, Palmer SM, Weber JM, Kim GHJ, Li P, Leonard TB, Goldin J on behalf of the ILD-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | Changes in lung function and changes in patient-reported outcomes in patients with idiopathic pulmonary fibrosis (IPF). Todd JL, Neely ML, Hellkamp AS, Culver DA, Oldham JM, Li P, Palmer SM on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Poster | 2024 | Circulating prostasin: an independent risk marker in idiopathic pulmonary fibrosis (IPF). Todd JL, Page C, Wu P, Belperio JA, Maher TM, Palmer SM, Leonard TB, Hesslinger C, Neely ML, Schlange T on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2024. | Abstract/Publication | Smart Poster |
| Publication | 2023 | Effect of antifibrotic therapy on survival in patients with idiopathic pulmonary fibrosis. de Andrade JA, Neely ML, Hellkamp AS, Palmer SM, Snyder LD | Abstract/Publication | |
| Publication | 2023 | Lung function trajectories in patients with idiopathic pulmonary fibrosis. Neely ML, Hellkamp AS, Bender S, Todd JL, Liesching T, Luckhardt TR, Oldham JM, Raj R, White ES, Palmer SM. | Abstract/Publication | |
| Publication | 2023 | Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. Ruan P, Todd JL, Zhao H, Liu Y, Vinisko R, Soellner JF, Schmid R, Kaner RJ, Luckhardt TR, Neely ML, Noth I, Porteous M, Raj R, Safdar Z, Strek ME, Hesslinger C, Palmer SM, Leonard TB, Salisbury ML. | Abstract/Publication | |
| Presentation | 2023 | Validation of a 25-gene blood transcriptomic signature predictive of forced vital capacity decline in patients with idiopathic pulmonary fibrosis. Bonham CA, Neely ML, Huang Y, Ma SF, Kim JS, Oldham JM, Becker K, Soellner J, Todd JL, Noth I on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2023. | Abstract/Publication | Smart Poster |
| Presentation | 2023 | Trajectories of health-related quality of life in patients with idiopathic pulmonary fibrosis. Olson AL, Todd JL, Snyder LD, Li P, Neely ML on behalf of the IPF-PRO Registry investigators. CHEST Annual Meeting 2023. | Abstract/Publication | Smart Poster |
| Presentation | 2023 | Utility of the 52-gene risk score to identify patients with idiopathic pulmonary fibrosis at greater risk of mortality in the era of antifibrotic therapy. Söllner JF, Bentink S, Hesslinger C, Leonard TB, Neely ML, Patel NM, Schlange T, Todd JL, Vinisko R, Salisbury ML on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2023. | Abstract/Publication | Smart Poster |
| Presentation | 2023 | Association of circulating metabolites with disease severity and mortality in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Summer R, Todd JL, Neely ML, Lobo LJ, Namen A, Newby LK, Shafazand S, Suliman S, Hesslinger C, Keller S, Leonard TB, Palmer SM, Ilkayeva O, Muehlbauer MJ, Newgard CB, Roman J on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2023. | Abstract/Publication | Smart Poster |
| Presentation | 2023 | Evaluation of content validity of a new exposure assessment questionnaire in patients with fibrosing interstitial lung diseases. Swaminathan AC, McFatrich M, Mkumba L, Wright L, Redlich CA, Snyder LD, Reeve BB, Olson AL, Gulati M. CHEST Annual Meeting 2023. | Abstract/Publication | Smart Poster |
| Presentation | 2023 | Association of HRCT patterns and progression in patients with progressive fibrosing interstitial lung diseases (ILDs) in the ILD-PRO Registry. Swaminathan AC, Whelan TPM, Neely ML, Todd JL, Palmer SM, Wojdyla D, Kim GHJ, Li P, Leonard TB, Conoscenti CS, Goldin J on behalf of the ILD-PRO Registry investigators. CHEST Annual Meeting 2023. | Abstract/Publication | Smart Poster |
| Poster | 2023 | Machine learning-based identification of RNA and protein biomarkers predictive of disease progression or death in the IPF-PRO Registry. Becker K, Soellner JF, Schlange T, Hesslinger C, Vinisko R, Leonard TB, Todd JL, Neely ML, Schmid R on behalf of the IPF-PRO Registry investigators. Becker K, Soellner JF, Schlange T, Hesslinger C, Vinisko R, Leonard TB, Todd JL, Neely ML, Schmid R on behalf of the IPF-PRO Registry investigators. | Online version not available | Smart Poster |
| Poster | 2023 | Characteristics of patients with progressive fibrosing ILDs in the ILD-PRO Registry. Lobo LJ, Liu Y, Li P, Ramaswamy M, Swaminathan AC, Veeraraghavan S, Fan Y, Neely ML, Palmer SM, Olson AL on behalf of the ILD-PRO Registry investigators. European Respiratory Society 2023. | Online version not available | Smart Poster |
| Poster | 2023 | Characteristics of patients with progressive fibrosing interstitial lung diseases (ILDs) in the ILD-PRO Registry. Lobo LJ, Liu Y, Li P, Ramaswamy M, Swaminathan AC, Veeraraghavan S, Fan Y, Neely ML, Palmer SM, Olson AL on behalf of the ILD-PRO Registry investigators. CHEST Annual Meeting 2023. | Abstract/Publication | Smart Poster |
| Poster | 2023 | Characteristics of patients with progressive fibrosing interstitial lung diseases in the ILD-PRO Registry by time between diagnosis and enrollment. Lobo LJ, Liu Y, Li P, Ramaswamy M, Swaminathan AC, Veeraraghavan S, Fan Y, Neely ML, Palmer SM, Olson AL on behalf of the ILD-PRO Registry investigators. CHEST Annual Meeting 2023. | Abstract/Publication | Smart Poster |
| Poster | 2023 | Trajectories of health-related quality of life (HRQL) in patients with idiopathic pulmonary fibrosis (IPF). Olson AL, Todd JL, Snyder LD, Li P, Neely ML on behalf of the IPF-PRO Registry investigators. European Respiratory Society 2023. | Online version not available | Smart Poster |
| Poster | 2023 | Association of circulating complement pathway gene expression with progression of idiopathic pulmonary fibrosis. Swaminathan AC, Neely ML, Belperio JA, Patel NM, Palmer SM, Todd JL on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2023. | Abstract/Publication | Smart Poster |
| Poster | 2023 | Circulating prostasin associates with presence and severity of idiopathic pulmonary fibrosis (IPF). Todd JL, Mulder H, Neely ML, Belperio JA, Lasky JA, Luckhardt TR, Palmer SM, Hesslinger C, Schlange T, Leonard TB on behalf of the IPF-PRO Registry investigators. European Respiratory Society 2023. | Online version not available | Smart Poster |
| Poster | 2023 | Circulating urokinase-type plasminogen activator receptor protein highly correlates with the severity of idiopathic pulmonary fibrosis (IPF): data from the IPF-PRO Registry. Todd JL, Neely ML, Belperio JA, Luckhardt TR, Palmer SM, Hesslinger C, Schlange T, Leonard TB on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2023. | Abstract/Publication | Smart Poster |
| Publication | 2022 | Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. de Andrade JA, Kulkarni T, Neely ML, Hellkamp AS, Case AH, Culver DA, Guntupalli K, Bender S, Conoscenti CS, Snyder LD. | Abstract/Publication | |
| Publication | 2022 | Clinical outcomes of patients with combined idiopathic pulmonary fibrosis and emphysema in the IPF-PRO Registry. Kim HJ, Snyder LD, Neely ML, Hellkamp AS, Hotchkin DL, Morrison LD, Bender S, Leonard TB, Culver DA. | Abstract/Publication | |
| Publication | 2022 | Disparities in lung transplant among patients with idiopathic pulmonary fibrosis: an analysis of the IPF-PRO Registry. Swaminathan A, Hellkamp AS, Neely ML, Bender S, Paoletti L, White ES, Palmer SM, Whelan TPM, Dilling DF. | Abstract/Publication | |
| Publication | 2022 | Association of circulating proteins with death or lung transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO Registry cohort. Todd JL, Neely ML, Overton R, Mulder H, Roman J, Lasky JA, de Andrade J, Gulati M, Huang H, Leonard TB, Hesslinger C, Noth I, Belperio JA, Flaherty KR, Palmer SM. | Abstract/Publication | |
| Presentation | 2022 | Characteristics of patients with progressive fibrosing interstitial lung diseases (ILDs): data from the ILD-PRO Registry. Lobo LJ, Bender S, Ramaswamy M, Swaminathan A, Palmer SM, Patel NM on behalf of the ILD-PRO Registry investigators. CHEST Annual Meeting 2022. | Abstract/Publication | Smart Poster |
| Presentation | 2022 | Circulating metabolic profile of idiopathic pulmonary fibrosis (IPF): data from the IPF-PRO Registry. Summer R, Todd JL, Neely ML, Lobo LJ, Namen A, Newby LK, Suliman S, Hesslinger C, Keller S, Leonard TB, Palmer SM, Newgard CB, Roman J on behalf of the IPF-PRO Registry investigators. International Colloquium on Lung and Airway Fibrosis (ICLAF) 2022. | Online version not available | Smart Poster |
| Presentation | 2022 | A multivariable protein-inclusive predictor of death or lung transplant in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Todd JL, Neely ML, Mulder H, Lancaster LH, White ES, Hesslinger C on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2022. | Abstract/Publication | Smart Poster |
| Poster | 2022 | Effect of antifibrotic therapy on survival in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. de Andrade JA,Neely ML, Hellkamp AS, Culver DA, Kim HJ, Liesching T, Lobo LJ, Ramaswamy M, Safdar Z, Bender S, Conoscenti CS, Palmer SM, Snyder LD. American Thoracic Society International Conference 2022. | Abstract/Publication | Smart Poster |
| Poster | 2022 | Lung function trajectories in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Neely ML, Bender S, Hellkamp AS, Todd JL, Liesching T, Luckhardt TR, Oldham JM, Raj R, White ES, Palmer SM on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2022. | Abstract/Publication | Smart Poster |
| Poster | 2022 | A clinical-molecular signature of progression of idiopathic pulmonary fibrosis (IPF). Oldham JM, Neely ML, Mulder H, Belperio JA, Patel NM, Hesslinger C, Todd JL on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2022. | Abstract/Publication | Smart Poster |
| Poster | 2022 | Gene-based collapsing genetic analyses to identify rare protein-coding variants associated with susceptibility to idiopathic pulmonary fibrosis (IPF): data from the IPF-PRO Registry. Povysil G, Todd JL, Allen AS, Dilling DF, Kim HJ, Neely ML, Noth I, Ren Z, Snyder LD, Strek ME, Swaminathan A, Zhang D, Hesslinger C, Leonard TB, Goldstein DB, Palmer SM on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2022. | Abstract/Publication | Smart Poster |
| Poster | 2022 | Integrative multi-omics analysis reveals biologically distinct endotypes of idiopathic pulmonary fibrosis (IPF). Ruan P, Todd JL, Zhao H, Liu Y, Vinisko R, Soellner JF, Schmid R, Kaner RJ, Luckhardt TR, Neely ML, Noth I, Raj R, Strek ME, Hesslinger C, Palmer SM, Leonard TB, Salisbury ML on behalf of the IPF-PRO Registry investigators. International Colloquium on Lung and Airway Fibrosis (ICLAF) 2022. | Online version not available | Smart Poster |
| Poster | 2022 | Integrative multi-omics analysis reveals novel endotypes of idiopathic pulmonary fibrosis (IPF) associated with disease progression. Ruan P, Todd JL, Zhao H, Liu Y, Vinisko R, Soellner JF, Schmid R, Kaner RJ, Luckhardt TR, Neely ML, Noth I, Raj R, Strek ME, Hesslinger C, Palmer SM, Leonard TB, Salisbury ML on behalf of the IPF-PRO Registry investigators. International Colloquium on Lung and Airway Fibrosis (ICLAF) 2022. | Online version not available | Smart Poster |
| Poster | 2022 | Association of genetic variants with disease progression in patients with idiopathic pulmonary fibrosis (IPF): data from the IPF-PRO Registry. Todd JL, Povysil G, Allen AS, Dilling DF, Kim HJ, Neely ML, Noth I, Ren Z, Snyder LD, Strek ME, Swaminathan A, Zhang D, Hesslinger C, Leonard TB, Goldstein DB, Palmer SM on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2022. | Abstract/Publication | Smart Poster |
| Publication | 2021 | Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. de Andrade J, Kulkarni T, Neely ML, Hellkamp AS, Case AH, Culver DA, Guntupalli K, Bender S, Conoscenti CS, Snyder LD. | Abstract/Publication | |
| Publication | 2021 | Hospitalizations in patients with idiopathic pulmonary fibrosis. Kim HJ, Snyder LD, Adegunsoye A, Neely ML, Bender S, White ES, Conoscenti CS, Strek ME. | Abstract/Publication | |
| Presentation | 2021 | Associations between circulating microRNAs and clinical outcomes in patients with IPF: data from the IPF-PRO™ Registry. Luckhardt TR, Neely ML, Mulder H, Belperio JA, Ramaswamy M, Salisbury ML, Hesslinger C, Palmer SM, Todd JL, Leonard TB. American Thoracic Society International Conference 2021. | Abstract/Publication | Smart Poster |
| Poster | 2021 | Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. de Andrade JA, Kulkarni T, Neely ML, Hellkamp AS, Case AH, Guntupalli K, Bender S, Conoscenti CS, Snyder LD. American Thoracic Society International Conference 2021. | Abstract/Publication | Smart Poster |
| Poster | 2021 | Characteristics of long-term survivors with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Kim HJ, Bender S, Patel NM, Neely ML, Conoscenti CS, Leonard TB, Palmer SM. CHEST Annual Meeting 2021. | Abstract/Publication | Smart Poster |
| Poster | 2021 | Associations between circulating matrix metalloproteinases and their inhibitors and mortality in patients with IPF: data from the IPF-PRO™ Registry. Todd JL, Neely ML, Overton R, Kaner RJ, Lasky JA, Namen A, Porteous MK, Hesslinger C, Leonard TB, Palmer SM, Belperio JA. American Thoracic Society International Conference 2021. | Abstract/Publication | Smart Poster |
| Poster | 2021 | Exploring relationships between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. de Andrade JA, Kulkarni T, Neely ML, Hellkamp AS, Case AH, Culver DA, Guntupalli K, Bender S, Conoscenti CS, Snyder LD. American Thoracic Society International Conference 2021. | Abstract/Publication | Smart Poster |
| Poster | 2021 | Disparities in lung transplantation among patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Swaminathan A, Hellkamp AS, Neely ML, Bender S, Paoletti L, White ES, Palmer SM, Whelan TPM, Dilling DF. American Thoracic Society International Conference 2021. | Abstract/Publication | Smart Poster |
| Poster | 2021 | Characteristics of patients with idiopathic pulmonary fibrosis admitted to hospital: data from the IPF-PRO Registry. Strek ME, Snyder LD, Adegunsoye A, Neely ML, Bender S, White ES, Conoscenti CS, Kim HJ. American Thoracic Society International Conference 2021. | Abstract/Publication | Smart Poster |
| Poster | 2021 | Post-hospitalization mortality in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Kim HJ, Snyder LD, Adegunsoye A, Neely ML, Bender S, White ES, Conoscenti CS, Strek ME. American Thoracic Society International Conference 2021. | Abstract/Publication | Smart Poster |
| Publication | 2020 | Associations between patient-reported outcomes and death or lung transplant in IPF: data from the IPF-PRO Registry. Case AH, Hellkamp AS, Neely ML, Bender S, Dilling DF, Gulati M, Hotchkin DL, Huie TJ, Lancaster L, Snyder LD, Conoscenti CS, Palmer SM. | Abstract/Publication | |
| Publication | 2020 | Hospital-based resource use and costs among patients with idiopathic pulmonary fibrosis enrolled in the idiopathic pulmonary fibrosis prospective outcomes (IPF-PRO) Registry. Fan Y, Bender S, Conoscenti CS, Davidson-Ray L, Cowper PA, Palmer SM, de Andrade JA. | Abstract/Publication | |
| Publication | 2020 | Disease severity and quality of life in patients with idiopathic pulmonary fibrosis: a cross-sectional analysis of the IPF-PRO Registry. O’Brien EC, Hellkamp AS, Neely ML, Swaminathan A, Bender S, Snyder LD, Culver DA, Conoscenti CS, Todd JL, Palmer SM, Leonard TB. | Abstract/Publication | |
| Publication | 2020 | Antifibrotic drug use in patients with IPF: data from the IPF-PRO Registry. Salisbury ML, Conoscenti CS, Culver DA, Yow E, Neely ML, Bender S, Hartmann N, Palmer SM, Leonard TB. | Abstract/Publication | |
| Publication | 2020 | Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry. Snyder LD, Mosher C, Holtze CH, Lancaster LH, Flaherty KR, Noth I, Neely ML, Hellkamp AS, Bender S, Conoscenti CS, de Andrade JA. | Abstract/Publication | |
| Publication | 2020 | Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort. Todd JL, Vinisko R, Liu Y, Neely ML, Overton R, Flaherty KR, Noth I, Newby LK, Lasky JA, Olman MA, Hesslinger C, Leonard TB, Palmer SM, Belperio JA. | Abstract/Publication | |
| Presentation | 2020 | Baseline characteristics of patients in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry. Culver DA, Yow E, Neely ML, Bender S, Dilling D, Oldham J, Palmer SM, Conoscenti CS. CHEST Annual Meeting 2020. | Abstract/Publication | Smart Poster |
| Presentation | 2020 | Association of neoepitopes with disease severity and respiratory hospitalization in patients with IPF. Oldham J, Todd JL, Neely ML, Mulder H, Overton R, Kim HJ, Gulati M, Leonard TB, Palmer S, Noth I, Hesslinger C. European Respiratory Society 2020. | Abstract/Publication | Smart Poster |
| Poster | 2020 | Integrative clustering analysis to discover novel IPF disease subtypes in the IPF-PRO Registry. Liu Y, Lin H, Soellner JF, Roy J, Vinisko R, Schmid R, Strobel B, Belperio JA, de Andrade J, Flaherty KR, Lasky JA, Luckhardt T, Neely ML, Hesslinger C, Palmer SM, Leonard TB, Todd JL, Salisbury M on behalf of the IPF-PRO Registry investigators. European Respiratory Society 2020. | Abstract/Publication | Smart Poster |
| Poster | 2020 | Relationship between mRNA-microRNA interactions and forced vital capacity in patients with idiopathic pulmonary fibrosis. Noth I, Roy J, Schmid R, Vinisko R, Strobel B, Neely ML, Hesslinger C, Belperio JA, Flaherty KR, Salisbury ML, Oldham J, Palmer SM, Todd JL, Leonard TB on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2020. | Abstract/Publication | Smart Poster |
| Poster | 2020 | Improving our understanding of progressive fibrosing interstitial lung diseases (ILDs): design of the ILD-PRO Registry. Palmer SM, Neely ML, Belperio JA, Bender S, Culver DA, de Andrade J, O'Brien EC, Roman J, Snyder LD, Todd JL, Whelan TPM, Leonard TB, Conoscenti CS on behalf of the ILD-PRO Registry investigators. American Thoracic Society International Conference 2020. | Abstract/Publication | Smart Poster |
| Poster | 2020 | Hospitalizations and Outcomes in Patients with Idiopathic Pulmonary Fibrosis (IPF): Insights from the IPF-PRO Registry. Kim HJ, Neely ML, Janssen KT, Agedunsoye A, Strek ME, Yow E, Conoscenti CS, Leonard TB, Snyder LD on behalf of the IPF-PRO Registry investigators. CHEST Annual Meeting 2020. | Abstract/Publication | Smart Poster |
| Poster | 2020 | Outcomes of patients with combined idiopathic pulmonary fibrosis (IPF) and emphysema in the IPF-PRO Registry. Kim HJ, Snyder LD, Neely ML, Hellkamp AS, Hotchkin DL, Morrison LD, Bender S, Leonard TB, Culver DA. CHEST Annual Meeting 2020. | Abstract/Publication | Smart Poster |
| Poster | 2020 | Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO™ Registry. Snyder LD, Mosher C, Holtze CH, Lancaster LH, Flaherty KR, Noth I, Neely ML, Hellkamp AS, Bender S, Conoscenti CS, de Andrade JA, Whelan TPM. American Thoracic Society International Conference 2020. | Online version not available | Smart Poster |
| Poster | 2020 | Association of circulating proteins with death or lung transplant in the IPF-PRO™ Registry cohort. Todd JL, Neely ML, Overton R, Mulder H, Roman J, Lasky JA, de Andrade J, Gulati M, Huang H, Leonard TB, Hesslinger C, Noth I, Belperio JA, Flaherty KR, Palmer SM. American Thoracic Society International Conference 2020. | Online version not available | Smart Poster |
| Publication | 2019 | Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. Snyder L, Neely ML, Hellkamp AS, O'Brien E, de Andrade J, Conoscenti CS, Leonard T, Bender S, Gulati M, Culver DA, Kaner RJ, Palmer S, Kim HJ. | Abstract/Publication | |
| Publication | 2019 | Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry. Todd JL, Neely ML, Overton R, Durham K, Gulati M, Huang H, Roman J, Newby LK, Flaherty KR, Vinisko R, Liu Y, Roy J, Schmid R, Strobel B, Hesslinger C, Leonard TB, Noth I, Belperio JA, Palmer SM. | Abstract/Publication | |
| Presentation | 2019 | The circulating metabolome in idiopathic pulmonary fibrosis. Hesslinger C, Overton R, Keller S, Neely ML, Belperio JA, Vinisko R, Leonard T, Flaherty KR, Noth I, Palmer SM, Todd JL. European Respiratory Society 2019. | Abstract/Publication | Smart Poster |
| Poster | 2019 | Peripheral blood gene expression profiling in the multicenter IPF-PRO™ Registry cohort. Noth I, Roy J, Schmid R, Strobel B, Leparc G, Vinisko R, Neely ML, Belperio JA, Hesslinger C, Leonard T, Palmer SM, Todd JL on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2019. | Abstract/Publication | Smart Poster |
| Poster | 2019 | Health-related quality of life measures in idiopathic pulmonary fibrosis: data from the IPF-PRO™ Registry. Swaminathan AC, O'Brien EC, Hellcamp AS, Neely ML, Bender S, Snyder LD, Culver DA, Conoscenti CS, Todd JL, Palmer SM on behalf of the IPF-PRO Registry investigators. CHEST Annual Meeting 2019. | Online version not available | Smart Poster |
| Poster | 2019 | Disease severity and quality of life in patients with idiopathic pulmonary fibrosis (IPF): an analysis of the IPF-PRO™ Registry. O'Brien EC, Hellcamp AS, Neely ML, Swaminathan AC, Bender S, Snyder LD, Culver DA, Conoscenti CS, Todd JL, Palmer SM, Leonard TB on behalf of the IPF-PRO Registry investigators. CHEST Annual Meeting 2019. | Online version not available | Smart Poster |
| Poster | 2019 | Associations between patient-reported outcomes and death or lung transplant in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO™ Registry. Case AH, Hellkamp AS, Neely ML, Bender S, Dilling DF, Gulati M, Huie TJ, Lancaster L, Snyder LD, Conoscenti CS, Palmer SM on behalf of the IPF-PRO Registry investigators. | Online version not available | Smart Poster |
| Poster | 2019 | Peripheral blood proteomic profiling to distinguish disease biomarkers in the multicenter IPF-PRO™ Registry cohort. Todd JL, Durham K, Overton R, Neely ML, Belperio JA, Gulati M, Huang HJ, Roman J, Newby LK, Noth I, Vinisko R, Yi L, Hesslinger C, Leonard T, Flaherty KR, Palmer SM on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2019. | Online version not available | Smart Poster |
| Poster | 2019 | Association of circulating proteins with disease-specific measures in the multicenter IPF-PRO™ Registry cohort. Todd JL, Neely ML, Overton R, Gulati M, Huang HJ, Roman J, Flaherty KR, Vinisko R, Hesslinger C, Leonard T, Noth I, Palmer SM, Belperio JA on behalf of the IPF-PRO Registry investigators. American Thoracic Society International Conference 2019. | Online version not available | Smart Poster |
| Poster | 2019 | Treatment patterns in patients with idiopathic pulmonary fibrosis (IPF): data from the IPF-PRO™ Registry. Salisbury ML, Conoscenti CS, Culver DA, Yow E, Neely ML, Bender S, Hartmann N, Palmer SM, Leonard TB. American Thoracic Society International Conference 2019. | Online version not available | Smart Poster |
| Poster | 2018 | Predictors of death or transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO Registry. Snyder LD, Neely ML, Hellkamp A, O'Brien EC, Flaherty KR, de Andrade J, Conoscenti CS, Leonard T, Bender S, Gulati M, Culver DA, Kaner RJ, Palmer SM, Kim HJ. European Respiratory Society 2018. | Abstract/Publication | |
| Poster | 2018 | Characteristics of patients with idiopathic plmonary fibrosis (IPF) in the US: data from the IPF-PRO Registry. Culver DA, Yow E, Neely ML, Belperio JA, Bender S, de Andrade J, Roman J, Whelan T, Palmer SM, Conoscenti CS. CHEST Annual Meeting 2018. | Abstract/Publication | |
| Poster | 2018 | Timing of lung transplant in patients with idiopathic pulmonary fibrosis. Snyder LD, Palmer SM, Neely ML, Yow E, Bender S, Flaherty KR, Leonard T, Conoscenti CS. CHEST Annual Meeting 2018. | Abstract/Publication | |
| Poster | 2018 | Hospital-Based Resource Use and Costs amongst Patients with Idiopathic Pulmonary Fibrosis Enrolled in the IPF-PRO Registry. Fan Y, Bender S, Conoscenti CS, Knight JD, Davidson-Ray L, Cowper PA, Palmer SM, de Andrade J. Academy of Managed Care Pharmacy Nexus 2018. | Online version not available | |
| Poster | 2018 | Associations between patient-reported outcomes and death or lung transplant in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Case AH, Hellkamp AS, Neely ML, Bender S, Dilling DF, Gulati M, Huie TJ, Lancaster LH, Snyder L, Conoscenti CS, Palmer SM. International Colloquium on Lung and Airway Fibrosis (ICLAF) 2018. | Online version not available | |
| Poster | 2018 | Peripheral Blood Matrix Metalloproteinase Profiling in the Multicenter IPF-PRO Registry. Cohort Todd J, Vinisko R, Neely M, Overton AJ, Flaherty K, Noth I, Hesslinger C, Leonard T, Palmer S, Belperio J. International Colloquium on Lung and Airway Fibrosis (ICLAF) 2018. | Online version not available | |
| Poster | 2018 | Survival in patients with idiopathic pulmonary fibrosis (IPF): data from the IPF-PRO registry. Palmer SM, Snyder L, Neely ML, Yow E, Bender S, Culver DA, de Andrade J, Gulati M, Kaner RJ, Leonard T, O'Brien E, Pushlar N, Conoscenti CS. American Thoracic Society International Conference 2018. | Online version not available | |
| Publication | 2017 | Underutilization of Lung Transplant Referral Among Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF). Paoletti L, Palmer S, Yow E, Neely ML, Gamerman V, Whelan T. International Society for Heart and Lung Transplantation 2017. | Abstract/Publication | |
| Poster | 2017 | Clinical characteristics of patients with advanced idiopathic pulmonary fibrosis (IPF). de Andrade JA, Whelan T, Luckhardt T, Lancaster L, Gamerman V, Kulkarni T, Neely ML, Yow E, O’Brien E, Conoscenti CS on behalf of the IPF-PRO™ Registry investigators. American Thoracic Society International Conference 2017. | Abstract/Publication | |
| Poster | 2017 | How do patients with idiopathic pulmonary fibrosis (IPF) in the real world compare with eligibility criteria for clinical trials? Gamerman V, Salisbury M, Culver D, Leonard T, Neely ML, Yow E, Conoscenti CS, Palmer S. CHEST Annual Meeting 2017. | Abstract/Publication | |
| Poster | 2017 | Description of diagnostic processes undertaken for patients with idiopathic pulmonary fibrosis enrolled in the IPF-PRO Registry. Holtze CH, Salisbury ML, Sheth JS, Belloli EA, White ES, Neely ML, Yow E, Gamerman V, Flaherty KR. American Thoracic Society International Conference 2017. | Online version not available | |
| Poster | 2017 | Prevalence of pulmonary hypertension in newly diagnosed patients with idiopathic pulmonary fibrosis (IPF) enrolled in the IPF-PRO Registry. Sheth JS, Belloli E, Salisbury M, Holtze CH, Yow E, Neely ML, Conoscenti CS, White E, Flaherty KR on behalf of the IPF-PRO™ Registry investigators. American Thoracic Society International Conference 2017. | Abstract/Publication | |
| Poster | 2017 | Composite Physiologic Index (CPI) Categorization and Gender Age Physiology (GAP) Stage Correlation and Differentiation of Patient-Reported Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis (IPF). Leonard T, O’Brien EC, Gamerman V, Yow E, Neely ML, Conoscenti CS, Culver DA. American Thoracic Society International Conference 2017. | Abstract/Publication | |
| Poster | 2017 | Characteristics of patients with idiopathic pulmonary fibrosis (IPF) receiving approved anti-fibrotic therapies in the US. Gamerman V, Salisbury M, Culver D, Leonard T, Neely ML, Yow E, Conoscenti CS, Palmer S. American Thoracic Society International Conference 2017. | Online version not available | |
| Poster | 2017 | Patient journey to diagnosis of idiopathic pulmonary fibrosis (IPF) in the US. Whelan TPM, Conoscenti CS, Flaherty KR, Holtze CH, Neely ML, Yow E, Snyder LD, de Andrade JA. European Respiratory Society 2017. | Abstract/Publication | |
| Poster | 2017 | Time From First Imaging Showing Pulmonary Fibrosis to Diagnosis of Idiopathic Pulmonary Fibrosis: Data From the IPF-PRO Registry. de Andrade JA, Conoscenti CS, Flaherty KR, Holtze CH, Lancaster L, Neely ML, Snyder LD, Yow E, Whelan TPM. CHEST Annual Meeting 2017. | Abstract/Publication | |
| Publication | 2016 | Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry. O'Brien EC, Durheim MT, Gamerman V, Garfinkel S, Anstrom KJ, Palmer SM, Conoscenti CS. | Abstract/Publication | |
| Poster | 2016 | Disease Severity and Quality of Life in Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients. O'Brien EC, Shrader P, Durheim MT, Snyder LD, Todd JL, Gamerman V, Anstrom KJ, Belperio JA, Culver DA, de Andrade JAM, Roman J, Whelan TPM, Conoscenti CS, Palmer SM. American Thoracic Society International Conference 2016. | Abstract/Publication | |
| Presentation | 2015 | Newly Diagnosed IPF at Tertiary Care Pulmonary Centers: Initial Results From the Idiopathic Pulmonary Fibrosis - PROspective Outcomes (IPF-PRO) Registry. Durheim M, O’Brien E, Gamerman V, Todd JL, Snyder LD, Anstrom K, Palmer S, Conoscenti C. CHEST Annual Meeting 2015. | Abstract/Publication | |
| Poster | 2014 | Design and Rationale of the Idiopathic Pulmonary Fibrosis: Prospective Outcomes (IPF-PRO) Registry. O'Brien E, Durheim M, Gamerman V, Garfinkel S, Anstrom K, Palmer S, Conoscenti C. CHEST Annual Meeting 2014. | Abstract/Publication |
For more information on the Registry or our research, please contact us at IPF-PRO@dm.duke.edu.